US 10836741
Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors
granted A61PA61P1/04A61P13/12
Quick answer
US patent 10836741 (Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors) held by Valo Early Discovery, Inc. expires Mon Nov 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Valo Early Discovery, Inc.
- Grant date
- Tue Nov 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 28
- CPC classes
- A61P, A61P1/04, A61P13/12, A61P21/02, A61P25/00